
Viewpoints | Jan 15,2022
April 2 , 2022
By Morounfolu (Folu) Olugbosi (MD) ( senior director of Clinical Development at TB Alliance. He works with the clinical development of products in the TB Alliance portfolio and helps to oversee clinical trials in TB endemic countries and heads the South Africa office. )
As countries around the world - from Kenya to Canada, South Africa to Sweden - relish the prospect of an unofficial transition of COVID-19 from pandemic to endemic and start to ease pandemic-related restrictions, many of us in the tuberculosis (TB) community find it hard to relate. In TB, we know what can happen when a pandemic becomes an accepted fact.
Understandably, people everywhere are eager to return to normal. COVID-19, the thinking goes, has evolved to be milder, so it is time to stop worrying and get on with our lives. Although the virus is still present, many think it has reached endemic levels and so restrictions are being lifted worldwide, despite warnings from more than a few epidemiologists.
There is no shortage of pandemics that continue to plague humanity. Malaria killed more than 620,000 people in 2020. TB was responsible for the deaths of more than 1.5 million people in 2020, and more than a third of these deaths took place in Sub-Saharan Africa.
Prior to COVID-19, hope was on the horizon that the TB pandemic was beginning to ebb. Over the past decade, case rates and fatalities had been slowly declining while research and development efforts had yielded breakthroughs.
After four decades without new medicines approved to treat TB, three have been approved in the past ten years. New technology can not only diagnose TB more easily and quickly than before but also determine if the infection has any drug resistance. That counts as progress in the TB world - but there is always the challenge of getting the technologies to the people who need it. And that is where the COVID-19 pandemic really hit hard.
In 2020, the most recent statistics that we have for TB, the number of deaths equals that of 2017, with five years of progress eliminated. An estimated 9.9 million people had TB infections, but only 5.8 million were diagnosed. We lost 10 years of progress in this benchmark. And only about one-third of the estimated 450,000 people with multi-drug resistant TB or Rifampin-resistant TB started treatment in 2020, a 15pc decrease from the previous year.
In Africa, countries like Nigeria, South Africa and Uganda had been making progress against TB, with deaths from the disease steadily declining, but these declines ended—all because of the COVID-19 pandemic and related control measures.
In 2015, the world pledged to reduce deaths from TB by 90pc by the year 2030, and we are nowhere close to achieving this goal. Epidemiologists evaluating the impact of this failure found that, before the COVID-19 pandemic began, sub-Saharan Africa had been hit hard by TB, with a heavy economic impact and significant loss of life from failing to meet this ambitious benchmark.
And yet, the World Health Organisation (WHO) reports that, in sub-Saharan Africa, domestic spending on TB prevention, diagnostic and treatment services has declined over the past 10 years. It is no wonder the pressures of COVID-19 tore apart the TB safety net. We too, in Africa, had decided it was ok to live with a lethal disease.
Yes, overall global spending on the disease is less than half of what it needs to be but for us in Africa, TB is not a disease of somewhere else. It is here and we need to roll up our sleeves and fight back or will never stop plaguing us.
No disease should be tolerated, especially deadly infections like TB and COVID-19. All diseases need to be tackled with new technologies and the outreach needed to make sure they are used appropriately. Endemic is never good enough.
PUBLISHED ON
Apr 02,2022 [ VOL
23 , NO
1144]
Viewpoints | Jan 15,2022
Radar | Jun 25,2022
Addis Fortune | May 07,2022
Radar | Apr 30,2022
Fortune News | Nov 09,2019
Fortune News | Apr 17,2021
Radar | Sep 19,2020
Commentaries | Jun 25,2022
Commentaries | Dec 05,2018
Fortune News | Apr 22,2022
Photo Gallery | 54519 Views | May 06,2019
Fortune News | 47056 Views | Jul 18,2020
Photo Gallery | 46340 Views | Apr 26,2019
Fortune News | 46062 Views | Sep 01,2021
July 2 , 2022 . By RUTH TAYE
On a rainy afternoon last week, a coffee processing facility in the capital's Akaki-Qality District was abuzz with activ...
November 27 , 2021
Against my will, I have witnessed the most terrible defeat of reason and the most sa...
November 13 , 2021
Plans and reality do not always gel. They rarely do in a fast-moving world. Every act...
October 16 , 2021 . By HAWI DADHI
Residing in a country with no capital market, an organised marketplace for trading se...
August 6 , 2022
Few initiatives by the administration of Prime Minister Abiy Ahmed (PhD) have been pu...
July 30 , 2022
Ethiopia’s banking industry is not merely underdeveloped. It has historically regre...
July 23 , 2022
The flip side of a government spending plan is financing. Behind the campaign promise...
July 17 , 2022
Messrs Ahmed Shide and Eyob Tekalegn (PhD), minister and state minister for Finance,...
August 6 , 2022
Champagne popped and poured; and a cake was cut to celebrate another milestone for Ethio telecom, still the only active operator in the coun...
August 6 , 2022 . By RAHEL BOGALE
The hospitality industry has entered the list of economic sectors that enjoy tax exemptions and incentive...
August 6 , 2022 . By RAHEL BOGALE
Federal authorities are contemplating the reversal of a decade-long ban on maize export. A team of expert...
August 6 , 2022 . By RUTH TAYE
Yodahe Zemichael seems determined to push the national ID project past the pilot stage, onboarding up to...
Put your comments here